CLINICAL_TRIALS
trial_result
· 2020-03-20
Clinical Trial Update: Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment [Phase 1]
Summary
Phase 1 pharmacokinetics study of voxilaprevir in adults with varying hepatic function completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: HCV Infection | Phase 1 | Status: COMPLETED | Results posted: 2020-03-20